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application of aggressive strategies of stsnt deployment leading to optimal 
results with quantitative angiogrepby. The clinical benefit of an IVUS guided 
approach of stant deployment and of a lower cost strategy based on QCA 
guidance shoutd be compared in prospective randomized studies. 
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~ '~ ls  There Benefit From Intravsscular Ultrasound a 
When High-Pressure Stent Expansion Is Routinely 
Perform,~l Prior to Ultrasound Imaging? 
Stsven L. Goldberg, Patrick Hall, Shigeru Nakamura, Luigi Malelfo, 
Yaron AImagor, Jonathan Tobis, Antonio Colombo. Contro Coors 
Columbus, Milan, Italy, Harbor-UCLA Medical Center, Torrance, CA 
When high-pressure balloon inflations (HPBrs) are routinely performed ur- 
ing stent deployment, itis unclear if intravascular ultrasound (IVUS) imaging, 
adds any additional benefit. A rotmspective analysis was performed of 305 
consecutive lesions slanted with IVUS guidance after HPBrs. IVUS criteria 
for optimal slanting was: 1 ) Intrastent cross-sectional rea (CSA) was > dis- 
tal "normal" lumen CSA, and 2) No potential f ow-limiting lesions proximal or 
distal to the stented segment ware seen. "IVUS improvement" was defined 
as 1) > 25% increase in intrastent CSA when further inflations were made 
due to findings from IVUS, or 2) ,stenting of a potentially flow-flmifing lesion 
proximal or distal to the stented segment, identified by IVUS. Results: The 
mean inflation pressure prior to IVUS was 14.7 4- 3.2 arm. Only 47% of 
stectsd lesions were identified as optimal by the first IVUS imaging. CSA 
increased from 6.94 4- 2.02 mrn ~ at the time of the first IVUS imaging to 8.04 
4- 1.93 mme when finished (p < 0.001). "IVUS improvement" was seen in 
39%: 26% (8,3/315) with an increase in CSA >_ 25% and 16% (51/315) with 
additional slanting for disease identified by IVUS as potentially flow-limiting. 
Conclusion: IVUS imaging after high-pressure bell~on inflation inside 
slants demonstrates optimal results in only 47% of lesions. WUS-guidance 
leads to significant improvements in anatomic appearance 39% of the time. 
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~5-1  IS Intravascular Necessary Ultrasound Guidance 
When Using the Johnson-Johnson Slant Without 
Anticeagutation 
Christopher M. Goods, Larry S. Dean, Ming W. I_iu, Khaled F. AI-Shalbi, 
Srirem S. lyero J. Michael Parks, Ronald J, Sutor, Gary S. Roubin. University 
of Alabama at Birmingham, Birmingl;am, AL 
Between 9/94 and 8/95, 95 patients (pts) had Johnson-Johnson stents ira. 
pianted in native coronary arteries. Eighty two pts receiving 114 stents were 
s,~!scted to receive antiplatelet therapy only, 73 pts were treated with Aspirin 
and "riclopidine and 9 lots with Aspirin alone. Patients were selected for an- 
flplaletet therapy based on angiogmphic riteria, i.e. no significant residual 
stanosls, uncovered issection, tilling defect, or outflow obstruction following 
high pressure balloon inflations. Intravascular ultrasound was not used to 
assist in this process. Indications for stenting were suboptimal rosuifs (25 
lots), lesion restenosis (7 tots), ostlal lesions (26 pts) and de-novo stenting 
(24 pts). The vessel slanted was the LAD (31 pts), RCA (45 pts), LCX (6 pts) 
and LM (6 pts). Forty four pts received biliary stents. The average stent size 
was 3.49 4- 0.36 ram, range 3-5 ram. 
Results: Thhly day follow up was available in all eligible pts (n = 77). No 
pt had slant thrombosis. There were no deaths or Q-wave myocardial infarc- 
tions and no pt required bypass surgery. Non-Q-wave myocardial infarction 
occurred in 2 nts (2.4%). Bleeding requiting blood transfusion occurred In 
one pt (1.2%/. 
Conclusion: In this group of pts, stent thrombosis did not occur and the 
incidence of comorbldify was low. Intravascular ultrasound increases pro- 
cedural time and cost and appears to be unnecessary before removing 
anticoagulalion from post stsnflng protocols. 
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~ An~lography Versus Intravsscular 
Ultrasound-Dirscted Stent Placement 
Robert J. Russo, Paul S. Talrstein, for the A.V.I.D. Investigators. Scripps 
Clinic and Research Foundation, La Jcila, CA 
In the A.V.I.D. [Angiography vs. Inlravascular Ultrasound (IVUS)-Dlrected 
Stent Placement] muificenter trial, patient outcome after IVUS-directed stent 
placement is compared to stent placement directed by angiogrspby. After 
an optimal angiographic result is obtained, patients are randomized to an- 
giography or tVUS-directed therapy. In the angiogrephy arm, blinded IVUS is 
performed and the patient discharged on aspirin 325 rag/day and ticlopidine 
500 rag/day for 4 weeks. In the tVUS-directed arm, patients who fail IVUS 
crltsri:-'; are treated with larger balloons. Patients who fulfill IVUS criteria (< 
10% stenosie and full slant apposition) am discharged on aspirin and tiolopl- 
dine. Patients who fail IVUS or anglogrephlc riteria receive enoxapadn (70 
mg/day) for 2 weeks in addition to aspirin and ticlopidine. Endpoints include 
stent thrombosis, death, MI, urgent bypass or repeat intervention within 30 
days and target lesion revascularlzation at6 and 12 months. To date, 163 pa- 
tients have been randomized and 136 am eligible for 30-day follow-up. Mean 
length of stay is 1.88 days :1:1.44 in the IVUS group and 1.46 days :1:0.96 in 
the angingraphy group (p = ns). In the IVUS group, 33% of patients required 
additional therapy to fulfill IVUS criteria. At 30-day follow-up, 2 pts (2.9%) in 
the angiography group and 1 (1.5%) in the IVUS group experienced acute 
in-hospital stsnt thrombosis (p ,, ns); 1 pt (1.4%) in the anglography group 
died and none in either group required urgent bypass or repeat intervention. 
Conclusion: To date, IVUS-directed stent implantation has not influenced 
the 30-day clinical event rate; 6- and 12-roonth follow-up is pending. 
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~9~-]  Macrophages, Smooth Muscle Cells and Tissue 
Factor in Unstable Angina: Implications for Cell 
Mediated Thrambogenicity in Acute Coronary 
Syndromes 
Pedro R. Moreno, MD, Victor H. Bemardi, MD, Julio Lopoz-Cualtsr, MD, Igor 
R Palaclos, MD, Herman K. Gold, MD, Yale Nemerson, MD, Valantin Fuster, 
MD, PhD, John T. Fallon, MD, PhD. Massachusetts General Hospital, 
Boston, MA; Harvard Medical School, Boston, MA; Cardiovescular Institute, 
New York, New York, Mount Sinai School of Medicine, New York, New York 
Macrophagas (MACS) and smooth muscle cells (SMC) have been implicated 
in the pathophvsiology of acute coronary syndromes. The lipid-rich atherema- 
tous gruel is a potent hmmboganio subetrate and macrophage xpression of 
tissue factor (1"[=), mw be responsible for its thrombogeniclty. SMC may be 
involved in the thrombotic response of lesions without plaque n~ture. This 
study was designed to identify cellular correlations ol TF content in coronary 
plaque tissue from patients with unstable angina. Computerized planimetry 
was used for systematic quantification of tissue charactedstiss of 50 direc- 
tional coronary atherectomy specimens from patients with unstable angina. 
Total and segmental areas (mt~) were identified with trichrome staining and 
Included coitagon-fich sclerotic tissue, hyperoellular tissue, fibroceflular tis- 
sue, atherornstous gruel and thrombus. MACS, SMC and TF were identified 
with monoclonal antibody (KP-1), alpha actin and polyclonal TF antibody re- 
spectively. A total of 1207 pieces of tissue were quantified. Multiple stepwise 
regression analysis showed that coronary TF content could be predicted 
reliably (r = 0.83, P < 0.0001) on the basis of MACS and SMC plaque areas. 
Colocalization analysis in the atherometous gruel demonstrated a strong 
relationship between TF content and MACS areas (r ,- 0.98, P < 0.0001). 
These results show that TF content in coronary plaque tissue correlated 
with areas of MACS and SMC. Furthermore, TF content in the alheromatous 
gruel is probably mediated by MACS suggesting a call-mediated thrombo- 
genicify in patients with acute cerenary syndromes. 
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~ 2 7  Fibrinogen and C-rosstlve Protein Are Strong 
Prognostic Markers in Unstable Coronary Artery 
Disease 
Henrik Toss, Agoeta Slegbohn 1, tars Wallentln. Dept. of Cardiology, 
Uppsala, Sweden; 1 Clin. Chemistry, University Hospital, Uppsala, Sweden 
A total of 546 patients were included in a randomized, placebo controlled, 
double blind, multicantsr study evaluating the effect of daltspadn, a low 
molecular weight hsparin, in unstable coronmy artery disease, i.e. unstable 
angina bectoris or non-Q-wave AMI. Patients with newly developed or in- 
creased angina pectoris during the last two months, and with latest episode 
CRP mg/L Fib. g/L 
< 7 > 7 p < 3.58 > 3.58 p 
(n = 269) (n - 273) (n = 275) (n = 271 )
d,~0 Death 0.7 3.7 < 0.05 0 4.4 < 0.001 
% +AMI 6.3 10.3 0.1 5.8 11.1 < 0.05 
d 150 Death 2.2 8.1 < 0.01 2.9 7.4 < 0.05 
% +AMI 11.9 18.7 < 0.05 11.3 19,6 < 0.01 
